Last reviewed · How we verify

NCT05374148

Respiratory Health Problems Among Workers in Ferrosilicon Alloys Industry in Aswan-Eygpt.

Status unknown Last updated 16 May 2022
What this trial tests

trial testing health education in Respiratory Disease in 250 participants. Status unknown.

Timeline
1 September 2022
Primary endpoint
1 September 2023
1 October 2023

Quick facts

Lead sponsorAssiut University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment250
Start date1 September 2022
Primary completion1 September 2023
Estimated completion1 October 2023

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 18 to 60, any sex, with Respiratory Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To minimize the negative effects of exposure to silica, iron chips, and coke on the respiratory health of workers in the Ferro alloy factory, so it is important to assess and diagnose their health-related effects. Early reporting, diagnosis, and intervention can limit the severity of health hazards, improve health services. To our knowledge, no local previous studies were done in this area. All over the world there is no sufficient information relating to this industry and its health hazards.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of health education

Trials testing the same drug.

Other recruiting trials for Respiratory Disease

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05374148.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing